SCI Abstract

search
Expanding treatment indications in chronic hepatitis B: Should we treat all patients?
Expanding treatment indications in chronic hepatitis B: Should we treat all patients?
Nucleos(t)ide analogues (NUCs) are first-line agents for chronic hepatitis B (CHB). Current guidelines provide recommendat...
Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation
Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation
Hepatocellular carcinoma (HCC) is the most prevalent type of primary liver cancer, characterized by a high rate of recurre...
Acute kidney injury stage 1a increases mortality of patients with cirrhosis: a prospective multicenter cohort study
Acute kidney injury stage 1a increases mortality of patients with cirrhosis: a prospective multicenter cohort study
Acute kidney injury is a severe complication of cirrhosis. However, the impact of mild decreases in renal function is cont...
Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis
Safety of tenofovir alafenamide in the context of hyperlipidemia and cardiovascular diseases: a nationwide analysis
Despite numerous small-scale studies, the correlation between tenofovir alafenamide fumarate (TAF) and hyperlipidemia rema...
Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysis
Global prevalence, metabolic characteristics, and outcomes of lean-MAFLD: a systematic review and meta-analysis
Metabolic Dysfunction-Associated Fatty Liver disease (MAFLD) among lean individuals is increasingly recognized. We aimed t...
Explainable attention-enhanced heuristic paradigm for multi-view prognostic risk score development in hepatocellular carcinoma
Explainable attention-enhanced heuristic paradigm for multi-view prognostic risk score development in hepatocellular carcinoma
Existing prognostic staging systems depend on expensive manual extraction by pathologists, potentially overlooking latent ...
Variceal band ligation and carvedilol: together forever, or not?
Variceal band ligation and carvedilol: together forever, or not?
We extend our congratulations to Tevethia et al for their recently published ‘CAVARLY trial’, which suggests the combinati...
Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma
Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma
Recently, we were intrigued by a recent study by Montironi et al,1 in which they discovered that an inflamed subclass in h...
Environmental and healthcare trade-offs between single-use and reusable gastroscopes
Environmental and healthcare trade-offs between single-use and reusable gastroscopes
We would like to offer some critical observations regarding the recent article published on the environmental impact of si...
Unravelling lipidomic disruptions across multiple tissues in Chd8-mutant ASD mice through integration of lipidomics and single-cell transcriptomics
Unravelling lipidomic disruptions across multiple tissues in Chd8-mutant ASD mice through integration of lipidomics and single-cell transcriptomics
With great interest, we read the article by Lou et al,1 who reported deviated gut microbiota in children with autism spect...
Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?
Is the biogeography of the mucosa-associated microbiota a key factor affecting primary sclerosing cholangitis disease course and treatment?
We have read with interest the contribution by Bedke et al,1 reporting changes in the stool microbiota associated with pri...
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD
TNF-like cytokine 1A (TL1A) and its functional receptor, death-domain receptor 3 (DR3), are members of the TNF and TNFR su...